Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals

Experimental Neurology
Meital Edri-BramiRachel G Lichtenstein

Abstract

We recently revealed a unique glycan on the Fc domain of IgG antibodies in ALS patients that mediates antibody-dependent cell cytotoxicity (ADCC). This glycan has a bi-antennary structure that lacks the core fucose and sialic acid residues but contains a bisecting GlcNAc (A2BG2). Little is known, however, about the incidence of A2BG2 expression and IgG cytotoxicity under ALS conditions within well-defined clinical stages. Here, we characterize the IgG antibodies produced in ALS Tg mice by detecting intra- and extra-cellular antigens of motor neurons that express different glycan patterns during the disease. The increased number of innate immune cells found at the disease onset was insufficient to induce an optimal systemic T-cell response. Nevertheless, IgG antibodies were produced against intracellular antigens at the pre-symptomatic stage in the secondary lymphoid organs under the conditions of a poor systemic immune response. Moreover, while the glycosyltransferases of plasma B-cells that synthesize the Fc-glycans were regulated by IL-2 or IL-4, the observed glycosyltransferase pattern did not match that found in ALS Tg mice. We further found that A2BG2 glycan is specific for ALS, its quantity increased with disease progress...Continue Reading

References

Aug 1, 1990·European Journal of Immunology·S AmigorenaJ L Teillaud
Nov 1, 1990·Archives of Neurology·J I Engelhardt, S H Appel
Jan 1, 1988·The Journal of Experimental Medicine·C M SnapperW E Paul
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D Herlyn, H Koprowski
Jan 1, 1993·Archives of Neurology·J I EngelhardtS H Appel
Sep 11, 2003·Journal of Neuroimmunology·Changying LingZsuzsa Fabry
May 4, 2005·Trends in Immunology·Antonio UccelliVito Pistoia
Dec 13, 2005·Molecular and Cellular Neurosciences·Jenny S HenkelStanley H Appel
Aug 5, 2006·Science·Yoshikatsu KanekoJeffrey V Ravetch
Apr 19, 2008·Science·Robert M AnthonyJeffrey V Ravetch
Aug 21, 2008·Journal of Molecular Neuroscience : MN·Nirit LevDaniel Offen
Sep 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Heike AlbertFalk Nimmerjahn
Nov 8, 2008·Journal of Visualized Experiments : JoVE·Melanie P Matheu, Michael D Cahalan
Sep 5, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jenny S HenkelStanley H Appel
Nov 26, 2009·Proceedings of the National Academy of Sciences of the United States of America·Isaac M ChiuMichael C Carroll
Nov 26, 2009·Nature Reviews. Immunology·Carola G VinuesaMatthew C Cook
Feb 27, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Albert C LudolphStephan von Horsten
Nov 11, 2010·Journal of Neuroinflammation·Milan FialaMartina Wiedau-Pazos
Dec 24, 2010·Brain, Behavior, and Immunity·David R BeersJenny S Henkel
Mar 5, 2011·Molecular & Cellular Proteomics : MCP·Jun WangManfred Wuhrer
Jul 5, 2011·Current Opinion in Neurology·Mamede de Carvalho, Michael Swash
Dec 14, 2011·Nature Reviews. Immunology·Michael McHeyzer-WilliamsLouise McHeyzer-Williams
Feb 1, 2012·Annals of the New York Academy of Sciences·Robert M AnthonyJeffrey V Ravetch
Aug 7, 2012·The Journal of Clinical Investigation·Oleg ButovskyHoward L Weiner
Nov 13, 2012·EMBO Molecular Medicine·Jenny S HenkelStanley H Appel
Apr 9, 2013·The Journal of Clinical Investigation·Margaret E AckermanGalit Alter
Mar 7, 2014·Frontiers in Immunology·Leen Moens, Stuart G Tangye

❮ Previous
Next ❯

Citations

Nov 9, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Karen R GarnaasMikki Behnke
Jun 15, 2019·International Journal of Molecular Sciences·Laura Moreno-MartinezRosario Osta
Nov 12, 2020·Frontiers in Aging Neuroscience·Katie MayneAlerie G de la Fuente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.